Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Romain

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
International Journal of Cancer|March 10, 2001
DNA-synthesizing enzymes in breast cancer (thymidine kinase, thymidylate synthase and thymidylate kinase): association with flow cytometric S-phase fraction and relative prognostic importance in node-negative premenopausal patientsS Romain, P O Bendahl, O Guirou, et al.
Obstetrics and Gynecology|January 1, 1995
Clinical and biologic prognostic factors in breast cancer diagnosed during postmenopausal hormone replacement therapyP Bonnier, S Romain, P L Giacalone, et al.
International Journal of Cancer|July 17, 1995
Age as a prognostic factor in breast cancer: relationship to pathologic and biologic featuresP Bonnier, S Romain, C Charpin, et al.
Anticancer Research|May 16, 2000
EORTC receptor and biomarker study group report analytical and technical evaluation of a thymidine kinase radio-enzymatic assay in breast cancer cytosolsP Span, J Heuvel, S Romain, et al.
European Journal of Cancer (Oxford, England : 1990)|June 5, 2012
A nomogram to predict individual prognosis in node-negative breast carcinomaC Mazouni, F Spyratos, S Romain, et al.
Breast Cancer Research and Treatment|January 1, 1994
Prognostic value of a solubilized fraction of EGF receptors in primary breast cancer using an immunoenzymatic assay--a retrospective studyF Spyratos, P M Martin, K Hacène, et al.
British Journal of Cancer|December 24, 2010
Epstein-Barr virus as a marker of biological aggressiveness in breast cancerC Mazouni, F Fina, S Romain, et al.
International Journal of Cancer|March 29, 1995
Prognostic value of cytosolic thymidine kinase activity as a marker of proliferation in breast cancerS Romain, I J Christensen, O Chinot, et al.
Bulletin Du Cancer|September 8, 1999
[Standardization and quality control in the evaluation of proliferation parameters in T1T2, N0N1, M0 breast cancer: multicentric retrospective study II. DNA-ploidy and S-phase fraction]A Chassevent, M L Jourdan, M Ferrero-Poüs, et al.
Bulletin Du Cancer|January 1, 1990
[Prognostic value of thymidine kinase in cancer of the breast]S Romain, J L Javre, S Samperez, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
International Journal of Cancer|March 10, 2001
DNA-synthesizing enzymes in breast cancer (thymidine kinase, thymidylate synthase and thymidylate kinase): association with flow cytometric S-phase fraction and relative prognostic importance in node-negative premenopausal patientsS Romain, P O Bendahl, O Guirou, et al.
Obstetrics and Gynecology|January 1, 1995
Clinical and biologic prognostic factors in breast cancer diagnosed during postmenopausal hormone replacement therapyP Bonnier, S Romain, P L Giacalone, et al.
International Journal of Cancer|July 17, 1995
Age as a prognostic factor in breast cancer: relationship to pathologic and biologic featuresP Bonnier, S Romain, C Charpin, et al.
Anticancer Research|May 16, 2000
EORTC receptor and biomarker study group report analytical and technical evaluation of a thymidine kinase radio-enzymatic assay in breast cancer cytosolsP Span, J Heuvel, S Romain, et al.
European Journal of Cancer (Oxford, England : 1990)|June 5, 2012
A nomogram to predict individual prognosis in node-negative breast carcinomaC Mazouni, F Spyratos, S Romain, et al.
Breast Cancer Research and Treatment|January 1, 1994
Prognostic value of a solubilized fraction of EGF receptors in primary breast cancer using an immunoenzymatic assay--a retrospective studyF Spyratos, P M Martin, K Hacène, et al.
British Journal of Cancer|December 24, 2010
Epstein-Barr virus as a marker of biological aggressiveness in breast cancerC Mazouni, F Fina, S Romain, et al.
International Journal of Cancer|March 29, 1995
Prognostic value of cytosolic thymidine kinase activity as a marker of proliferation in breast cancerS Romain, I J Christensen, O Chinot, et al.
Bulletin Du Cancer|September 8, 1999
[Standardization and quality control in the evaluation of proliferation parameters in T1T2, N0N1, M0 breast cancer: multicentric retrospective study II. DNA-ploidy and S-phase fraction]A Chassevent, M L Jourdan, M Ferrero-Poüs, et al.
Bulletin Du Cancer|January 1, 1990
[Prognostic value of thymidine kinase in cancer of the breast]S Romain, J L Javre, S Samperez, et al.
Pageof 6